AgomAb Therapeutics N.V. American Depositary (AGMB) Technical Analysis

As of 2026-07-22, AGMB last traded at 11.6 USD (-0.34% on the day) and is in a range on the daily timeframe — insufficient history for 200-DMA. Nearest levels: 11.53 USD support below, 11.93 USD resistance above. 14-day RSI is 47.5 (neutral).

Last updated 2026-07-22 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

Is AGMB in an uptrend or downtrend?

AgomAb Therapeutics N.V. American Depositary is in a range — insufficient history for 200-DMA.

Last close11.6 USD (-0.34%)
20-day average12.872 USD
50-day average11.721 USD
200-day averagen/a

Key support and resistance levels for AGMB

Derived from swing pivots over the last 114 sessions:

LevelTypeStrengthTouches
11.93 USDResistanceMinor1
12.65 USDResistanceMinor1
13 USDResistanceMinor1
LevelTypeStrengthTouches
11.53 USDSupportMinor1
10.24 USDSupportMinor1
10.1 USDSupportMinor1

AGMB 52-week range, momentum and volatility

52-week high17.82 USD (34.9% below)
52-week low8.75 USD (32.6% above)
14-day RSI47.5 (Neutral)
14-day ATR1.014 USD (8.74% of price, High volatility)

Related research pages

Frequently asked questions

Is AgomAb Therapeutics N.V. American Depositary (AGMB) in an uptrend or downtrend?

As of 2026-07-22, AGMB is in a range on the daily timeframe — insufficient history for 200-DMA. Last close 11.6 USD vs 50-day average 11.721 USD and 200-day average n/a.

What are the key support and resistance levels for AGMB?

Nearest support is around 11.53 USD (minor, 1 touch). Nearest resistance is around 11.93 USD (minor). Levels are derived from swing pivots over the last ~200 sessions.

What is AGMB's 52-week high and low?

Over the last 52 weeks, AGMB traded between 8.75 USD and 17.82 USD. It is currently 34.9% below its 52-week high.

Is AGMB overbought or oversold?

The 14-day RSI is 47.5 — in a neutral 30–70 range. Momentum reads as neutral.

How volatile is AGMB?

Its 14-day Average True Range is 1.014 (8.74% of price) — high volatility relative to price.